Immuron
IMRN
4 hedge funds and large institutions have $15.6K invested in Immuron in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0.07% less ownership
Funds ownership: 0.21% → 0.14% (-0.07%)
34% less capital invested
Capital invested by funds: $23.8K → $15.6K (-$8.2K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$4.26K |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$3.45K |
IMRN Hedge Fund Activity: Q3 2023 in Review
4 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q3 2023, worth a combined $15.6K — down 34% from $23.8K a quarter earlier.
Fund positioning in IMRN was balanced in Q3 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Morgan Stanley, cutting an estimated $4.26K.
- 4 institutional investors held Immuron (IMRN) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $15.6K of Immuron stock for Q3 2023, down 34% quarter-over-quarter.
- 0 funds opened new Immuron positions in Q3 2023 and 0 closed out.
- The largest Immuron seller in Q3 2023 was Morgan Stanley, an estimated $4.26K sold.
Based on aggregated 13F filings for Q3 2023.